Gemmer Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-225
Closed -$22K 1490
2019
Q3
$22K Buy
225
+16
+8% +$1.52K 0.01% 370
2019
Q2
$19K Buy
209
+15
+8% +$1.42K 0.01% 409
2019
Q1
$18K Buy
194
+14
+8% +$1.22K ﹤0.01% 459
2018
Q4
$12K Sell
180
-41
-19% -$3.03K ﹤0.01% 559
2018
Q3
$20K Hold
221
0.01% 411
2018
Q2
$18K Sell
221
-15
-6% -$1.25K 0.01% 456
2018
Q1
$21K Sell
236
-94
-28% -$9.02K 0.01% 393
2017
Q4
$34K Sell
330
-19
-5% -$2.14K 0.01% 263
2017
Q3
$51K Hold
349
0.02% 179
2017
Q2
$45K Sell
349
-40
-10% -$4.9K 0.02% 194
2017
Q1
$48K Buy
389
+2
+0.5% +$239 0.02% 182
2016
Q4
$45K Buy
387
+6
+2% +$668 0.02% 181
2016
Q3
$40K Buy
381
+66
+21% +$7.14K 0.02% 196
2016
Q2
$31K Sell
315
-55
-15% -$5.69K 0.02% 216
2016
Q1
$37K Buy
370
+109
+42% +$11.2K 0.02% 199
2015
Q4
$31K Sell
261
-325
-55% -$37.6K 0.02% 217
2015
Q3
$63K Buy
586
+22
+4% +$2.73K 0.04% 136
2015
Q2
$65K Sell
564
-9
-2% -$1.03K 0.04% 148
2015
Q1
$66K Buy
573
+9
+2% +$1.07K 0.04% 145
2014
Q4
$63K Hold
564
0.04% 147
2014
Q3
$53K Hold
564
0.04% 165
2014
Q2
$48K Hold
564
0.03% 175
2014
Q1
$39K Buy
+564
New +$44.7K 0.03% 191

Other funds holding CELG

Gemmer Asset Management's CELG Position: Q4 2019 in Review

Gemmer Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 225 shares — an estimated $22K sold.

Gemmer Asset Management first reported a position in CELG in Q1 2014 and held it in 23 quarters. The position peaked at $66K in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Gemmer Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Gemmer Asset Management sold 225 Celgene Corp shares in Q4 2019, an estimated $22K.
  • Gemmer Asset Management first reported a position in Celgene Corp in Q1 2014 and held it in 23 quarters.
  • Gemmer Asset Management's Celgene Corp position peaked at $66K in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Gemmer Asset Management's 13F filing for Q4 2019, filed 17 Jan 2020.